SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule -- Ignore unavailable to you. Want to Upgrade?

To: Mike Winn who wrote (141)1/12/1998 9:46:00 PM
From: William Nelson  Respond to of 399
 
From the article it sounds like they announced what everyone expected
them to announce...maybe that was the disappointment.

My sense is that momentum is building for them and they will exceed
estimates for at least this year (does that matter in biotech??)
as lots of companies give them a try.

If their methods really are effective maybe a biggie will buy them
so they don't have to share.



To: Mike Winn who wrote (141)1/13/1998 12:16:00 PM
From: JZGalt  Read Replies (1) | Respond to of 399
 
Article in Forbes hit the subscribers in the past few days. ARQL mentioned in the table of companies involved in the technology of drug discovery. ABSC mentioned in article. ABSC got a pop, ARQL died. Go figure. ARQL has more collaborations.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News